These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8453028)

  • 1. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
    Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
    Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
    Lukey BJ; Woodard CL; Clark CR; McCluskey MP
    J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
    Spöhrer U; Thiermann H; Klimmek R; Eyer P
    Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral kinetics and bioavailability of the cholinesterase reactivator HI-6 after administration of 2 different formulations of tablets to dogs.
    Maksimović M; Jovanović D; Kovacević V; Bokonjić D
    Toxicol Lett; 1987 Nov; 39(1):85-91. PubMed ID: 3672559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.
    Clement JG; Bailey DG; Madill HD; Tran LT; Spence JD
    Biopharm Drug Dispos; 1995 Jul; 16(5):415-25. PubMed ID: 8527690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
    Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimedoxime and HI-6: kinetic comparison after intravenous administration to mice.
    Milic B; Maksimovic M; Nedelijkovic M
    Pharmacol Toxicol; 1996 Apr; 78(4):269-72. PubMed ID: 8861786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7.
    Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P
    Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of HI-6 in beagle dogs.
    Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1983; 4(4):375-88. PubMed ID: 6661515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the oxime HI-6 from a mixture with atropine sulphate in dogs.
    Jovanović D; Kovacević V; Maksimović M
    Pharmacol Toxicol; 1992 Nov; 71(5):340-2. PubMed ID: 1448446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
    Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
    Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatta): effect of atropine, diazepam, and methoxyflurane anesthesia.
    Clement JG; Lee MJ; Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1990 Apr; 11(3):227-32. PubMed ID: 2328309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HI-6 and 2-PAM in sheep: pharmacokinetics and effects on muscle tissue following intramuscular injection.
    Moore DH; Hayward IJ; Tucker FS; Lukey B
    Biopharm Drug Dispos; 1991 Apr; 12(3):223-32. PubMed ID: 2059672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent changes in concentration of two clinically used acetylcholinesterase reactivators (HI-6 and obidoxime) in rat plasma determined by HPLC techniques after in vivo administration.
    Zdarova Karasova J; Novotny L; Antos K; Zivna H; Kuca K
    Anal Sci; 2010 Jan; 26(1):63-7. PubMed ID: 20065589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector.
    Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA
    Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition kinetics, bioavailability and renal clearance of cefepime in calves.
    Ismail MM
    Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of poisoning by soman (pinacolyl methylphosphonofluoridate) on the serum half-life of the cholinesterase reactivator HI-6 in mice.
    Clement JG; Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1988; 9(2):177-86. PubMed ID: 3370306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of benzydamine in dairy cows following intravenous or intramuscular administration.
    Anfossi P; Malvisi J; Catraro N; Bolognini M; Tomasi L; Stracciari GL
    Vet Res Commun; 1993; 17(4):313-23. PubMed ID: 8146956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.